Berlin — Germany cast doubt on the effectiveness of AstraZeneca’s Covid-19 shot for the elderly in a move that could perpetuate the EU’s vaccine supply shortages.

The country’s immunisation commission recommended that the drugmaker’s inoculation be authorised only for people between the ages of 18 and 64, according to a draft assessment released on Thursday by the German health ministry...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.